If a pharmaceutical company funds a double-blind clinical trial performed by highly respected medical researchers, are the results relevant?
Not necessarily.
Click below to find out the rest of the story.
http://www.chicagosuntimes.com/output/otherviews/cst-edt-ref11.html
Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.
